These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29897495)

  • 1. The future of myocardial injury biomarkers in cardiovascular disease: looking beyond cardiac troponins.
    Marber M
    Cardiovasc Res; 2018 May; 114(6):e39-e40. PubMed ID: 29897495
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations.
    Everett BM
    Trends Cardiovasc Med; 2017 Jan; 27(1):41-47. PubMed ID: 27422097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?
    Tsounis D; Deftereos S; Bouras G; Giannopoulos G; Anatoliotakis N; Raisakis K; Kossyvakis C; Cleman MW
    Curr Top Med Chem; 2013; 13(2):201-15. PubMed ID: 23470078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.
    Roberts MA; Hedley AJ; Ierino FL
    Nephrology (Carlton); 2011 Mar; 16(3):251-60. PubMed ID: 21342319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease].
    Michelini Truedsson M; Stagmo M; Alm Hirsch I; Malm J; Marko-Varga G; Piitulainen E
    Lakartidningen; 2020 Feb; 117():. PubMed ID: 32096867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19, cardiovascular diseases and cardiac troponins.
    Kim CW; Aronow WS
    Future Cardiol; 2022 Feb; 18(2):135-142. PubMed ID: 34476978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients.
    Neill F; Sear JW; French G; Lam H; Kemp M; Hooper RJ; Foex P
    Anaesthesia; 2000 Jul; 55(7):641-7. PubMed ID: 10919418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Sensitivity Troponins in Cardiovascular Disease.
    Kontos MC; Turlington JS
    Curr Cardiol Rep; 2020 Mar; 22(5):30. PubMed ID: 32232671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heartbeat: Prediction of coronary disease risk with cardiac troponin in the general population.
    Otto CM
    Heart; 2016 Aug; 102(15):1151-2. PubMed ID: 27406718
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patients.
    Mavrakanas TA; Sniderman AD; Barré PE; Alam A
    Nephrology (Carlton); 2018 Jan; 23(1):69-74. PubMed ID: 27718506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin in Cardiovascular Disease Prevention: Updates and Future Direction.
    Hoff J; Wehner W; Nambi V
    Curr Atheroscler Rep; 2016 Mar; 18(3):12. PubMed ID: 26879078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troponins: established and novel indications in the management of cardiovascular disease.
    Giannitsis E; Katus HA
    Heart; 2018 Oct; 104(20):1714-1722. PubMed ID: 29724751
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.
    Jansen H; Jaensch A; Schöttker B; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
    J Am Heart Assoc; 2019 Jun; 8(12):e011882. PubMed ID: 31189389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with cardiac troponin assessments].
    Hadarits F; Iván A; Márkus C; Nagy L
    Orv Hetil; 2009 Oct; 150(43):1988-93. PubMed ID: 19812021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponins and chronic kidney disease.
    Kanderian AS; Francis GS
    Kidney Int; 2006 Apr; 69(7):1112-4. PubMed ID: 16531987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrochemical cardiovascular platforms: Current state of the art and beyond.
    Szunerits S; Mishyn V; Grabowska I; Boukherroub R
    Biosens Bioelectron; 2019 Apr; 131():287-298. PubMed ID: 30851492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent assay developments for cardiac troponins: are we sensitive enough to recognize the high sensitives?].
    Schulz O; Schimke I
    Herz; 2008 Nov; 33(7):526-31. PubMed ID: 19066749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occam, Hickam, Troponin, and Appropriate Use.
    Chapman GD
    Am J Med; 2017 Oct; 130(10):1131-1132. PubMed ID: 28602873
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial (hot topic: cardiovascular disease biomarkers: from tradition to modernity).
    Bouras G; Deftereos S
    Curr Top Med Chem; 2013; 13(2):79-81. PubMed ID: 23470071
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative myocardial cell injury: the role of troponins.
    Metzler H; Gries M; Rehak P; Lang T; Fruhwald S; Toller W
    Br J Anaesth; 1997 Apr; 78(4):386-90. PubMed ID: 9135358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.